openPR Logo
Press release

2032, Drug-eluting Stents Market Size, Share and Forecast Report [Market Data Library]

08-08-2023 01:29 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Data Library

Drug-Eluting Stents Market

Drug-Eluting Stents Market

According To Market Data Library, The Global Drug-Eluting Stents Market Reached US$ 8.8 Billion In Terms Of Revenue In 2022 And Is Forecast To Be Valued At US$ 12.1 Billion In 2031. Between 2023 And 2031, Market Revenue Is Expected To Register A Compound Annual Growth Rate (CAGR) Of 3.6%, And Factors Driving This Projected Growth Are Provided In Much Detail Along With Tables, Charts, Infographics, As Well As Supporting Information And Forecasts In The Report.  

"Access critical market data and analysis for free - download our sample report now!" https://marketdatalibrary.com/download-sample/14464

Drug-Eluting Stents Market Analysis & Insights  

Drug-Eluting Stents Are Utilized In The Treatment Of Coronary Artery Disease And Are Inserted Into The Narrowed Or Blocked Coronary Arteries Of Patients With Atherosclerosis. These Stents Are Constructed From Medical-Grade Stainless Steel Or Cobalt Alloy Metal And Are Designed To Expand And Hold The Artery Open. The Stents Have A Specialized Coating Made Of Polymer That Contains A Drug, Which Is Slowly Released To Prevent Blockages And Improve Blood Flow Within The Artery. This Technology Is Commonly Employed In Procedures Such As Coronary Angioplasty And Percutaneous Coronary Interventions (PCI). Each Drug-Eluting Stent Consists Of Three Components: The Stent Platform, The Polymer Coating That Retains The Drug Within The Stent, And The Drug Itself.

Research Scope  

Drug-Eluting Stents Market Dynamics  

"Rising Prevalence Of Cardiovascular Disease To Drive The Drug Eluting Stent Market"  

The Global Prevalence Of Cardiovascular Diseases (CVDs) Is Increasing Due To Various Factors Such As Changes In Lifestyle, Obesity, Diabetes, And Smoking. This Trend, Coupled With The Growing Healthcare Expenditure In Developing Countries, Is Expected To Drive The Demand For Drug-Eluting Stents In The Global Market. Furthermore, The Rising Incidence Of Peripheral Arterial Disease (PAD) Is Also Expected To Contribute To The Growth Of The Drug-Eluting Stent Market. For Instance, In The United States, It Has Been Reported By The National Center For Chronic Disease Prevention And Health Promotion That A Significant Number Of Individuals Aged 40 Years And Above Are Affected By PAD. This Is Anticipated To Fuel The Demand For Drug-Eluting Stents In Peripheral Stenting Procedures Worldwide.

"Introduction Of Advanced Drug Eluting Stent Is Projected To Drive Their Adoption In The Global Market"

Recent Advancements In Cardiovascular Interventions And The Development Of Bioresorbable Polymer-Based Drug-Eluting Stents (DES) Are Expected To Have A Significant Impact On The Expansion Strategies Of Manufacturers In The DES Market. The Introduction Of Technologically Advanced Stents Is A Key Driver For Market Growth In The Forecast Period. For Example, In February 2019, Biotronik Received FDA Approval For Orsiro, An Ultrathin DES Designed For Use In Percutaneous Coronary Intervention Procedures. This Approval Opens Up Opportunities For Biotronik To Expand Its Market Presence.

" Frequent Product Recalls Is One Of The Major Elements Anticipated To Hamper The Market Growth"  

Despite Rising Prevalence Of Cardiovascular Disease And Introduction Of Novel And Technologically Advanced Drug Eluting Stent, There Have Been Several Product Recalls By Various Key Market Players. Frequent Product Recalls By Key Market Players Is Likely To Hamper The Growth Of The DES Market. For Instance, Boston Scientific Had Initiated A Voluntary Recall For Its 150mm Eluvia Drug Eluting Vascular Stent, As Well As Its 180mm And 200mm Innova Self-Expanding Stent System Due To Growing Number Of Issues Registered For Partial Stent Deployment Resulting Into Vessel Trauma And Prolongation Of The Implant Procedure.

To view Top Players, Segmentation and other Statistics of Drug-eluting Stents Industry, Get Free Customization Report: https://marketdatalibrary.com/free-customization/14464

"North America Is Expected To Hold A Significant Share In The Market And Expected To Do Same In The Forecast Period"  

North America Is Anticipated To Dominate The Drug-Eluting Stent Market, Primarily Due To Favorable Reimbursement Policies And A High Incidence Rate Of Artery Diseases In The Region. The Presence Of Advanced Healthcare Infrastructure And Ongoing Technological Advancements In Drug-Eluting Stents Further Contribute To The Market Growth. According To Data From The Center For Disease Control And Prevention (CDC) In July 2022, It Is Projected That 20.1 Million Adults Aged 20 And Older Will Be Affected By Coronary Artery Disease In 2020. Additionally, Approximately 805,000 Americans Experience A Heart Attack Each Year. The Economic Impact Of Heart Disease In The United States Amounts To An Estimated USD 229 Billion Annually. These Statistics Illustrate The Growing Burden Of Heart Diseases And The Substantial Healthcare Expenditure Associated With Them, Which Are Expected To Drive The Demand For Drug-Eluting Stents In The Region. The Presence Of Favorable Reimbursement Policies Facilitates Patient Access To Drug-Eluting Stents, Making Them A Preferred Treatment Option For Physicians And Patients. Moreover, The Well-Established Healthcare Infrastructure In North America Supports The Adoption Of Advanced Medical Technologies And Procedures, Including Drug-Eluting Stents.

Regional Insights:  

During The Projected Period, Germany Will Continue To Be The Most Lucrative Market For Drug-Eluting Stents. The Asia Pacific Region Is The Largest Market For Drug-Eluting Stents With A Large Consumer Base.

The Asia Pacific Region Is Anticipated To Expand At The Fastest CAGR From 2022 To 2030. Countries Like Germany, France, And The United Kingdom Also Support The Provision Of Drug-Eluting Stents Market. Asia Pacific Also Has A Mature Drug-Eluting Stents Market. 

Download Our Free Sample Report to Learn More: https://marketdatalibrary.com/download-sample/14464

Key Companies And Competitive Landscape:  

Companies Included In The Report Are:  

Boston Scientific Corporation
Abbott
Medtronic
Biotronik
Terumo Corporation
MicroPort Scientific Corporation
Sahajanand Medical Technologies
Others

Report Segmentation:  

The Market Report Is Segmented According To Type, Scaffold, Drug, End User And Region As Shown Below:  

Type

Coronary Stenting
Peripheral Stenting

Scaffold

Cobalt-Chromium
Platinum-Chromium
Nitinol
Others

Drug

Sirolimus
Paclitaxel
Zotarolimus
Everolimus
Others

End User

Hospitals
Specialty Clinics

Region  

North America  
Latin America  
Europe  
Asia Pacific  
Middle East & Africa 

About Market Data Library:

Market Data Library is committed to providing clients with high-quality market research that is tailored to their specific needs. The Market Data Library provides corporate intelligence studies that ensure reliable and accurate research data across a diverse range of industries, including Health Care, Chemicals, Packaging, ICT, Automotive, Industrial Automation, Agriculture, and Finance. Our team is comprised of various departments, including sales, operations, finance, research, and analytics, as well as the scientist and data scientist teams. Our business offerings portray the most up-to-date, rational information a company needs to compete effectively. To guarantee that our clients have access to information and insights whenever they need them, we provide 24/7 research support.

Contact Us

Market Data Library

Tel: +1-(718)-312-8686

Email sales@marketdatalibrary.com

Info info@marketdatalibrary.com

Website: marketdatalibrary.com/

LinkedIn | Facebook | Twitter

Latest Reports by MDL

https://marketdatalibrary.com/report-store/automotive-occupant-detection-system-market

https://marketdatalibrary.com/report-store/rare-inflammatory-disease-treatment-market

https://marketdatalibrary.com/report-store/renewable-solvent-market

https://marketdatalibrary.com/report-store/thermally-modified-wood-boards-market

https://marketdatalibrary.com/report-store/pharmaceutical-retail-market

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2032, Drug-eluting Stents Market Size, Share and Forecast Report [Market Data Library] here

News-ID: 3158283 • Views:

More Releases from Market Data Library

Air Compressors Market Soars with Rising Demand for Energy-Efficient and Portable Solutions, Reshaping Industry Landscapes
Air Compressors Market Soars with Rising Demand for Energy-Efficient and Portabl …
Thе global Air-Comprеssor markеt rеsеarch rеport providеs comprеhеnsivе insights into driving factors, rеstraints, opportunitiеs, and trеnds, with provision of in-dеpth supporting information, data, and statistics and actionablе insights. According to Market Data Library analysis, thе Air-Comprеssor markеt was US$ 28. 7 billion in 2022. Furthеrmorе, thе Air-Comprеssor markеt to rеgistеr a CAGR of 4. 8 % which is еxpеctеd to rеsult in
Unlocking Robotic Welding Market Growth: Overcoming Economic, Logistic, and Cost Barriers | Top Players: Panasonic Corporation, FANUC Corporation, YASKAWA Electric Corporation, KUKA AG
Unlocking Robotic Welding Market Growth: Overcoming Economic, Logistic, and Cost …
The global robotic welding market research report provides comprehensive insights into driving factors, restraints, opportunities, and trends, with the provision of in-depth supporting information, data, statistics and actionable insights. According to Market Data Library analysis, the Robotic Welding Market was US$ 7.44 billion in 2022. Furthermore, the robotic welding market to register a CAGR of 5.3 % which is expected to result in a market forecast value for 2031 of
Lipid Nanoparticles Market: Seizing Opportunities in Precision Medicine, Gene Therapy, and Beyond | Top Players - Genevant Sciences, Lonza Group AG, Rentschler Biopharma
Lipid Nanoparticles Market: Seizing Opportunities in Precision Medicine, Gene Th …
The global lipid nanoparticle market report provides comprehensive insights into driving factors, restraints, opportunities, and trends, with the provision of in-depth supporting information, data, and statistics and actionable insights. According to Market Data Library analysis, the Lipid Nanoparticle was US$ 161.7 Million. in 2022. Furthermore, the lipid nanoparticles market to register a CAGR of 13.80 % which is expected to result in a market forecast value for 2031 of US$
Insights Demand of Open-Source Database Market Competition Analysis, Revenue and Forecast Till 2031
Insights Demand of Open-Source Database Market Competition Analysis, Revenue and …
In the ever-evolving landscape of information technology, the Open-Source Database Market has emerged as a dynamic and influential player. With its roots deeply embedded in the principles of transparency, flexibility, and cost-efficiency, open-source databases have gained substantial traction. In this article, we delve into a comprehensive market research report on the Open-Source Database Market, covering segmentation, top key players, market growth, and segment analysis. Market Size and Share: According to Reports

All 5 Releases


More Releases for Stent

Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients